Author(s): Floriana Morgillo, Giampaolo Tortora and Fortunato Ciardiello
Page: [276 - 283] Pages: 8
* (Excluding Mailing and Handling)
In the last decades the epidermal growth factor receptor (EGFR), which is frequently expressed in a variety of epithelial tumors, has been a major target of molecular anticancer therapy.
Keywords: EGFR, Monoclonal antibody, Tyrosine kinase inhibitor, resistance
Download PDF Flyer